Reimbursement in Europe and Indication-specific Pricing - New Market Report Now Available
This report sets out pricing and reimbursement mechanisms across the major European markets, tracking the increasing importance of health technology assessments. The final chapter develops scenarios for setting a higher price in a subsequently approved indication, highlighting the key determinants of success.
View full press release